BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20197388)

  • 1. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
    Rubin EM; Guo Y; Tu K; Xie J; Zi X; Hoang BH
    Mol Cancer Ther; 2010 Mar; 9(3):731-41. PubMed ID: 20197388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
    Lin YC; You L; Xu Z; He B; Yang CT; Chen JK; Mikami I; Clément G; Shi Y; Kuchenbecker K; Okamoto J; Kashani-Sabet M; Jablons DM
    Hum Gene Ther; 2007 Apr; 18(4):379-86. PubMed ID: 17472570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of WIF-1 by hypermethylation in astrocytomas.
    Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y; Song T; Zeng F; Rao Y
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):418-25. PubMed ID: 20539942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
    Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1.
    Li W; Meng Z; Zou T; Wang G; Su Y; Yao S; Sun X
    Pathol Oncol Res; 2020 Jan; 26(1):533-539. PubMed ID: 30523602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
    Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
    Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
    Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
    Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
    Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
    Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
    Tan M; Wu J; Cai Y
    Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
    Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H
    Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.
    Kansara M; Tsang M; Kodjabachian L; Sims NA; Trivett MK; Ehrich M; Dobrovic A; Slavin J; Choong PF; Simmons PJ; Dawid IB; Thomas DM
    J Clin Invest; 2009 Apr; 119(4):837-51. PubMed ID: 19307728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
    Lin YC; You L; Xu Z; He B; Mikami I; Thung E; Chou J; Kuchenbecker K; Kim J; Raz D; Yang CT; Chen JK; Jablons DM
    Biochem Biophys Res Commun; 2006 Mar; 341(2):635-40. PubMed ID: 16427602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer.
    Liu YL; Yang HP; Zhou XD; Gong L; Tang CL; Wang HJ
    Curr Cancer Drug Targets; 2011 Nov; 11(9):1098-110. PubMed ID: 21933103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.